
Insulin Degludec Coupons & Discount Card – Guaranteed Prices from $104.15
generic Tresiba Flextouch, Tresiba
My prescription
Edit
10ML of 100UNIT/ML, Insulin Degludec (1 Vial)
Select pharmacy

CVS
$141.74
COUPON PRICE
Walmart
$104.15
COUPON PRICE
Walgreens
$110.15
COUPON PRICE
Rite Aid
$125.42
COUPON PRICE
Albertsons
$128.83
COUPON PRICEInsulin Degludec savings card
Show this card to your pharmacist
Walmart
$104.15
BIN
ID
PCN
GRP
019876
LH604CBB9C
CHIPPO
LHX
Powered by
More prescriptions for diabetes type 1
More prescriptions for diabetes type 1
Insulin Degludec dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
10ML of 100UNIT/ML | 1 Vial | $104.15 | $104.15 |
Insulin Degludec Warnings
The safety and warning information for insulin degludec (Tresiba) is crucial for ensuring its safe use. Please read the following points carefully and consult your healthcare provider if you have any questions or concerns:
Infection Risk from Pen Sharing: Do not share insulin degludec (Tresiba) pens, syringes, or needles with others. Sharing can lead to severe infections and other health risks for both parties.
Blood Sugar Level Fluctuations: Altering your insulin regimen, including the injection site, can impact insulin efficacy, potentially causing high or low blood sugar. Injecting into areas with lipodystrophy, such as pitted or thickened skin, may elevate blood sugar levels.
Hypoglycemia (Low Blood Sugar): Using insulin degludec (Tresiba) alone or with other blood-sugar-lowering medications can result in dangerously low blood sugar levels, which can be life-threatening if untreated. Factors that increase this risk include dietary and exercise changes, alcohol consumption, concurrent diabetes medications, and liver or kidney issues.
Hypokalemia (Low Potassium Levels): Insulin degludec (Tresiba) can decrease blood potassium levels, posing a risk when taken with potassium-lowering medications like certain diuretics. Regular monitoring of potassium levels may be necessary.
Fluid Retention and Heart Failure Risk: Combining insulin degludec (Tresiba) with glitazones, such as pioglitazone (Actos), may lead to fluid retention, exacerbating heart failure symptoms. This risk is higher in individuals with a history of heart failure.
Allergic Reactions: Though rare, serious allergic reactions, including anaphylaxis, can occur. Seek immediate medical attention if you experience symptoms like swelling of the lips, face, or tongue; rash; or difficulty breathing.
Contraindications:
- Insulin degludec (Tresiba) should not be used during episodes of hypoglycemia (low blood sugar), as it can pose serious health risks. Always consult your healthcare provider before using this medication under such conditions.
Insulin Degludec Side Effects
Common side effects:
- Low blood sugar levels
- Common cold symptoms
- Upper respiratory tract infections
- Headaches
- Diarrhea
- Sinus infections
- Stomach viral infections
- Injection site reactions (redness, swelling, or itching)
- Weight gain
- Fluid buildup
Serious side effects:
- Severely low blood sugar
- Dangerously low potassium levels
- Severe allergic reactions (rash, hives, swelling of the face, tongue, or throat, difficulty breathing)
Insulin Degludec Interactions
Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:
- Beta-blockers (metoprolol, propranolol, timolol)
Is insulin degludec the same as Lantus?
Insulin degludec and Lantus are not the same. Insulin degludec is a long-acting insulin marketed under the brand name Tresiba, while Lantus is the brand name for insulin glargine, another long-acting insulin. Both are used to manage blood sugar levels in individuals with diabetes, but they have different formulations and durations of action.
Is insulin degludec available in generic?
As of the latest information, insulin degludec is not available in a generic form. It is marketed under the brand name Tresiba.
What is a cheaper alternative to Tresiba?
A potential cheaper alternative to Tresiba (insulin degludec) could be other long-acting insulins such as insulin glargine (Lantus or its biosimilar Basaglar) or insulin detemir (Levemir). However, the choice of insulin should be made in consultation with a healthcare provider, as individual needs and responses to insulin can vary. Additionally, insurance coverage and available discounts may influence the cost-effectiveness of these alternatives.
What are the brands of degludec?
Degludec is available under the brand name Tresiba.
How much is insulin degludec without insurance?
The cost of insulin degludec without insurance can vary significantly depending on the pharmacy and location. On average, the price for a 10 mL vial can range from $300 to $400. It's advisable for individuals to check with local pharmacies for the most accurate pricing and explore any available discount programs or manufacturer coupons that might help reduce the cost.